Related Experiment Videos

Intravesical therapy for superficial bladder cancer: is it a wash?

K L Kilbridge, P Kantoff

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|January 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancer.

Urologic oncology·2021

Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases.

Prostate cancer and prostatic diseases·2017

Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels.

British journal of cancer·2008

No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk.

The Prostate·2008

The epidemic of prostate cancer and the medical literature: a causal association?

Prostate cancer and prostatic diseases·2002

See all related articles